EDITION : English/Korean

Nav
Updated

Actor Park Seo Joon Tests Positive For The COVID-19 Virus!

by Victoria Marian Belmis / Feb 24, 2022 12:45 PM EST
Park Seo Jun

"Itaewon Class" star actor Park Seo Joon has fallen ill! To the sadness of netizens and his personal fans, Korean actor Park Seo Joon has gone on to test positive for the COVID-19 virus.

READ: Netizens Excited As Park Seo Joon & Han So Hee Confirmed For Upcoming K-Drama 'Gyeongseong Creature'!

On the 24th of February, Park Seo Joon's agency Awesome ENT made it known to the public that the actor has been diagnosed with the COVID-19 virus. Though fans were assured that Park Seo Joon completed three doses of the COVID-19 vaccine, they are still taking every safety measure to ensure their star's safety alongside the people working around him.

READ: Lee Min Ho, Cha Eun Woo, Park Seo Jun, And Kim Seon Ho: Most Followed K-Drama Actors On Instagram

Park Seo Joon's agency Awesome ENT full statement is as follows:

"As a preemptive measure, Park Seo Joon carried out tests using self-testing kits before moving to all his filming sets. Before proceeding to his scheduled activity last week, he tested positive using a self-testing kit, so after carrying out a PCR test, he ultimately received a positive test on February 19.

Park Seo Joon has completed three doses of the COVID-19 vaccine, and he has halted all scheduled activities since February 18 and is taking the necessary measures to quarantine and receive treatment in keeping with the guidelines set by government health authorities.

He is currently in the recovery stage and has no special symptoms."

READ: Is IU Dating Park Seo Jun Or EXO's Baekhyun? Netizens Discuss Dispatch's Next 'New Year' Couple

Netizens and fans are wishing actor Park Seo Joon a quick recovery!

READ: Awesome ENT Confirms Park Seo Joon Is Joining The Marvel Cinematic Universe!

Stay tuned for more news and updates regarding your favorite K-drama and K-movie actors and actresses!

Like us and Follow us
© 2024 Korea Portal, All rights reserved. Do not reproduce without permission.
Connect with us : facebook twitter google rss

Subscribe to our Newsletter

Don't Miss

Real Time Analytics